Shape the Future of ACS! We want your feedback about the ACS brand and how we can serve you better into the future. Take the Survey!
The pharmaceutical industry makes products that improve millions of lives. Recent developments in flow chemistry can help alleviate the environmental burden of manufacturing processes to bring these products to market in a sustainable way. Belzutifan (MK-6482) is an investigational selective inhibitor of hypoxia-inducible factor-2α (HIF-2α) that is being evaluated for the treatment of kidney cancer.
Join François Lévesque and Cecilia Bottecchia of Merck as they share how the synthetic route designed for belzutifan reduced step count, eliminated waste, improved efficiency, and solved critical safety and robustness issues. Discover why the key enabler for this achievement was reimagining how an efficient radical bromination reaction can be achieved through a photo-flow process on manufacturing scale.
This ACS Webinar is moderated by John Tucker of Neurocrine Biosciencesand and co-produced with the ACS Green Chemistry Institute.